All NewsFDA BriefsOncology IconsSpecial ReportsVoices from the Field
Conference CoverageConference ListingData Dialogue with the Oncology Brothers
All VideosCase-Based Peer PerspectivesExpert Perspective Virtual Tumor BoardInterviewsInvestigator PerspectivesMedical World NewsPivotal Practice Views with the Oncology BrothersPodcastsPrecision Medicine
All PublicationsEvolving ParadigmsPeers & Perspectives in OncologyTargeted Therapies in Oncology
CME/CE
Case-Based Roundtable SeriesClinical TrialsPartnersPrecision Medicine PerspectivesPress ReleasesSponsored ContentTreatment Resources
eNewsletterPrint Subscription
BRAIN CANCER
BREAST CANCERBREAST CANCER
GENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERS
GENOMIC TESTINGGENOMIC TESTING
GI CANCERSGI CANCERSGI CANCERSGI CANCERSGI CANCERS
GYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGYHEMATOLOGY
IMMUNOTHERAPYIMMUNOTHERAPY
LEUKEMIASLEUKEMIASLEUKEMIASLEUKEMIAS
LUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCER
LYMPHOMASLYMPHOMASLYMPHOMASLYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERSSKIN CANCERS
THYROID CANCERS
Spotlight -
  • Biomarker-Driven Lung Cancer
  • GIST
  • HER2-Positive Breast Cancer
  • Chronic Lymphocytic Leukemia
  • Small Cell Lung Cancer
  • Renal Cell Carcinoma
BRAIN CANCER
BREAST CANCERBREAST CANCER
GENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERS
GENOMIC TESTINGGENOMIC TESTING
GI CANCERSGI CANCERSGI CANCERSGI CANCERSGI CANCERS
GYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGYHEMATOLOGY
IMMUNOTHERAPYIMMUNOTHERAPY
LEUKEMIASLEUKEMIASLEUKEMIASLEUKEMIAS
LUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCER
LYMPHOMASLYMPHOMASLYMPHOMASLYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERSSKIN CANCERS
THYROID CANCERS
    • CME/CE
Advertisement

mCRC with Tanios Bekaii-Saab, MD and Tara Seery, MD: Case 2

home / case-based-peer-perspectives / mcrc-2016-case-2

mCRC with Tanios Bekaii-Saab, MD and Tara Seery, MD

Advertisement

Tara Seery, MD: Fourth-Line Therapy in mCRC

EP. 1: Tara Seery, MD: Fourth-Line Therapy in mCRC

April 27th 2016

Watch


Tanios Bekaii-Saab, MD: Fourth-Line Therapy in mCRC

EP. 2: Tanios Bekaii-Saab, MD: Fourth-Line Therapy in mCRC

April 27th 2016

Watch


Tara Seery, MD: Clinical Data Supporting Trifluradine-Tipiracil

EP. 3: Tara Seery, MD: Clinical Data Supporting Trifluradine-Tipiracil

April 27th 2016

Watch


Tanios Bekaii-Saab, MD: Clinical Data Supporting Trifluradine-Tipiracil

EP. 4: Tanios Bekaii-Saab, MD: Clinical Data Supporting Trifluradine-Tipiracil

April 27th 2016

Watch


Tara Seery, MD: Impact of Third-Line Therapy

EP. 5: Tara Seery, MD: Impact of Third-Line Therapy

April 27th 2016

Watch


Tanios Bekaii-Saab, MD: Impact of Third-Line Therapy

EP. 6: Tanios Bekaii-Saab, MD: Impact of Third-Line Therapy

April 27th 2016

Watch

Advertisement

Tara Seery, MD: KRAS Status in mCRC

EP. 7: Tara Seery, MD: KRAS Status in mCRC

April 27th 2016

Watch


Tanios Bekaii-Saab, MD: KRAS Status in mCRC

EP. 8: Tanios Bekaii-Saab, MD: KRAS Status in mCRC

April 27th 2016

Watch


Tara Seery, MD; Chemotherapy as a Possible Option

EP. 9: Tara Seery, MD; Chemotherapy as a Possible Option

April 27th 2016

Watch


Tanios Bekaii-Saab, MD; Chemotherapy as a Possible Option

EP. 10: Tanios Bekaii-Saab, MD; Chemotherapy as a Possible Option

April 27th 2016

Watch

About Us
Advertise
Contact Us
CureToday.com
CancerNetwork.com
OncLive.com
OncNursingNews.com
Do Not Sell My Information
Privacy
Terms & Conditions
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.